Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Marie Lavollay"'
Autor:
Marie Lavollay, Céline Buon, Vincent Le Moigne, Fabrice Compain, Armel Guyonvarch, Matthieu Fonvielle
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Six genes encoding putative high molecular weight penicillin-binding proteins (Pbp) are present in the genome of the β-lactam-resistant strain Corynebacterium jeikeium K411. In this study, we show that pbp2c, one of these six genes, is present in re
Externí odkaz:
https://doaj.org/article/6ad56c0c787a49c3856a83eea6359f4b
Autor:
Fabrice Compain, Dominique Decré, Isabelle Frazier, Astrid Ramahefasolo, Marie Lavollay, Etienne Carbonnelle, Hidayeth Rostane, Arzu Tackin, Anne Berger-Carbonne, Isabelle Podglajen
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 7, Pp 1246-1248 (2014)
Externí odkaz:
https://doaj.org/article/299c1fcf60d644b4ba41430585064e0b
Autor:
Matthieu Monge, Soledad Henriquez, Caroline Humbert, Elsa Guiard, Mahmoud Allouache, Jean-Marc Yhuel, Marie Lavollay, Clemence Richaud, Afsaneh Gohari
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Casirivimab/imdevimab (C/I) is a combination of two neutralizing human monoclonal antibodies against the SARS-CoV-2. It has been approved for primary prophylaxis or acute SARS-CoV-2 infection in patients with a poor vaccine respon
Autor:
Astrid Ramahefasolo, Isabelle Podglajen, Marie Lavollay, Fabrice Compain, Salah Gallah, Guillaume Arlet, Catherine Eckert, Dominique Decré
Publikováno v:
Journal of Clinical Microbiology. 54:3065-3068
Carbapenemase-producing Enterobacteriaceae have become a major therapeutic challenge in hospital- and community-acquired infections worldwide ([1][1]). Several phenotypic and molecular methods for their rapid identification have been developed ([2][2
Publikováno v:
Journal of Medical Microbiology. 64:1256-1259
Autor:
Isabelle Podglajen, Iheb Kaibi, Philippe Morand, Jean-Luc Mainardi, Marie Lavollay, Gary Taieb, Fabrice Compain, Patrick Grohs
Ceftolozane-tazobactam was tested against 58 multidrug-resistant nonfermenting Gram-negative bacilli (35 Pseudomonas aeruginosa , 11 Achromobacter xylosoxydans , and 12 Stenotrophomonas maltophilia isolates) isolated from cystic fibrosis patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56779f8597bcbe60e3b7786af763fe74
https://europepmc.org/articles/PMC5365655/
https://europepmc.org/articles/PMC5365655/
Autor:
L. Gutmann, Jean-Louis Herrmann, Marie Lavollay, J.-L. Mainardi, Jean-Louis Gaillard, Beate Heym, Michel Arthur, Vincent Dubée
Publikováno v:
Clinical Microbiology and Infection. 20(5):O297-O300
The in vitro activity of cefoxitin and imipenem was compared for 43 strains of the Mycobacterium abscessus complex, mostly isolated from cystic fibrosis patients. The MICs of imipenem were lower than those of cefoxitin, although the number of imipene
Publikováno v:
Journal of Clinical Microbiology. 55:656-657
OXA-163 and OXA-405 have been described by Poirel et al. ([1][1]) and Dortet et al. ([2][2], [3][3]), respectively, as “the first class D β-lactamase compromising both extended-spectrum cephalosporin and carbapenem activities” and as having “c
The Peptidoglycan of Mycobacterium abscessus Is Predominantly Cross-Linked by l , d -Transpeptidases
Autor:
Laurent Gutmann, Michel Arthur, Jean-Louis Herrmann, Martine Fourgeaud, Jean-Luc Mainardi, Arul Marie, Marie Lavollay, Lionel Dubost
Publikováno v:
Journal of Bacteriology. 193:778-782
Few therapeutic alternatives remain for the treatment of infections due to multiresistant Mycobacterium abscessus . Here we show that the peptidoglycans of the “rough” and “smooth” morphotypes contain predominantly 3→3 cross-links generated
Autor:
Arzu Tackin, Astrid Ramahefasolo, Isabelle Podglajen, Anne Berger-Carbonne, Marie Lavollay, Fabrice Compain, Hidayeth Rostane, Dominique Decré, Etienne Carbonnelle, Isabelle Frazier
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 7, Pp 1246-1248 (2014)
Emerging Infectious Diseases
Emerging Infectious Diseases
To the Editor: The emergence and rapid worldwide dissemination of carbapenemase-producing bacteria (CPB), especially carbapenemase-producing Enterobacteriaceae (CPE), have prompted public health authorities to reconsider prevention strategies to cont